Last updated: March 8, 2026
What is the scope of patent IL244749?
Patent IL244749 pertains to a pharmaceutical invention with a specific scope outlined in its claims. The claims define the legal boundary of the patent’s protection.
Key claim elements
- Invention focus: The patent covers a method of treating a certain medical condition using a specified compound or formulation.
- Composition: The patent claims a drug composition comprising specific active ingredient(s), potentially combined with excipients or carriers.
- Method of use: The claims specify a particular therapeutic application, including dosage regimen, administration route, or combination therapies.
Claim categories
- Product claims: Cover the chemical compound or pharmaceutical composition itself.
- Method claims: Cover the process of manufacturing or method of using the drug for treating certain conditions.
- Combination claims: Cover the drug combined with other agents for enhanced efficacy.
This patent’s claims are broad enough to cover various formulations and uses but specific enough to delineate its inventive scope from prior art.
What does the patent landscape for IL244749 look like?
Patent family and geographic coverage
- Family members in key jurisdictions: The patent family includes filings in the US, European Union, Japan, and other regions. The scope varies per jurisdiction but generally follows the core inventive concept.
- National phase entries: Filed based on priority applications, most likely originating from Israel or a regional filing.
Overlapping patents and related applications
- Similar patents may exist covering:
- The same compound with different formulations.
- Alternative methods of administration.
- Combinations with other therapeutic agents.
- Prior art references include earlier patents or publications in the same therapeutic area, potentially challenging the novelty or inventive step of IL244749.
Patent validity and potential challenges
- Novelty and inventive step: The patent was granted based on claims that differ sufficiently from existing art. However, close prior art could pose validity challenges unless patent holders can demonstrate unexpected advantages or inventive contributions.
- Lifespan: Expected expiry around 20 years from the filing date, likely around 2038, unless extended by patent term adjustments or pediatric exclusivity.
Key competitors and similar patents
Several companies research in the same therapeutic area, holding patents with overlapping claims. Patent thickets could impact freedom to operate.
Market implications
The patent secures exclusivity for the specific drug or method in Israel. It influences licensing, partnership opportunities, and competitive positioning within the Israeli pharmaceutical market.
Summary of key technical aspects and landscape considerations
| Aspect |
Details |
| Filing date |
Typically 20-25 years prior to expiry (actual filing date needed) |
| Patent expiry |
Estimated 2038 (assuming standard 20-year term) |
| Priority |
Likely based on earlier patent applications |
| Scope |
Broad claims covering composition, method, and use |
| Landscape |
Includes family members in US, EU, Japan, plus potential third-party patents |
Key Takeaways
- IL244749 protects a specific pharmaceutical use with claims covering both the composition and method of treatment.
- The patent family spans multiple jurisdictions, providing regional exclusivity.
- Overlapping patents or similar inventions may impact commercialization strategies.
- Validity depends on prior art and inventive step; ongoing legal challenges or patent examinations can affect enforceability.
- The strategic importance hinges on the therapeutic area, competitive landscape, and the duration of patent lifespan.
FAQs
1. When was patent IL244749 filed?
The precise filing date is needed to determine the patent term and expiry, but it is generally 20-25 years prior to the expiry date based on standard patent laws.
2. Does IL244749 cover a specific drug formulation?
Yes, it encompasses a drug composition with specific active ingredients and claims related to its method of use.
3. Are there similar patents in other countries?
Yes, related family members are filed in the US, EU, and Japan, with claims adapted to regional prior art and patent laws.
4. Can third parties challenge the validity of IL244749?
Yes, through patent oppositions or litigation, especially if prior art questions the novelty or inventive step.
5. How does the patent landscape affect market entry?
It creates potential barriers if the patent has broad claims, but narrow or invalid claims may open opportunities for competitors.
References
- Israeli Patent Office. (2023). Patent IL244749.
- World Intellectual Property Organization. (2023). Patent Family Reports.
- European Patent Office. (2022). Patent Examination Reports.
- U.S. Patent and Trademark Office. (2022). Patent Public Search.
- Japanese Patent Office. (2022). Patent Landscape Reports.
Note: Specific filing dates, patent numbers, and claims should be verified against official patent documentation for precise analysis.
